|
|
Vol. 10.12 – 13 May, 2024
|
|
|
|
|
|
|
|
Scientists demonstrated that circCDK13 could stimulate the proliferation and migration of human dermal fibroblasts and human epidermal keratinocytes by interacting with insulin-like growth factor 2 mRNA binding protein 3 in an N6-Methyladenosine-dependent manner to enhance CD44 and c-MYC expression. [Nature Communications]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
DERMAL STEM CELLS & TISSUE REGENERATION
|
|
|
|
|
|
Investigators reported that melanoma-secreted melanosomes passaged through epidermal keratinocytes or dermal fibroblasts could be further engulfed by resident macrophages, which led to macrophage polarization into pro-tumor or pro-immune cell infiltration phenotypes. [EMBO Journal]
|
|
|
|
|
|
Researchers demonstrated that B-cell translocation gene (BTG) 3 levels were downregulated in basal cell carcinoma and squamous cell carcinoma compared to normal skin tissue, and Btg3 knockout in mice augmented the development of papilloma in a mouse model of skin carcinogenesis. [Cell Death & Differentiation]
|
|
|
|
|
|
Giant salamander skin mucus gel dressing wrapped with bone marrow mesenchymal stem cells was prepared and validated, and skin wound injury of rabbit and mouse models were established.
[Aging]
|
|
|
|
|
|
Scientists elucidated Twist2 expression and its role in fetal wound healing. Mouse fetuses were surgically wounded, and Twist2 expression in tissue samples from these fetuses were evaluated via in situ hybridization, immunohistochemistry, and reverse transcription-quantitative polymerase chain reaction.
[Scientific Reports]
|
|
|
|
|
|
|
|
Researchers identified a potent and selective inhibitor of C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) active in cellular and melanoma animal models. [Journal Of Experimental & Clinical Cancer Research]
|
|
|
|
|
|
|
|
The authors provide an overview of recent advancements in sebaceous glands (SG) organoid engineering. It highlights some potential strategies for SG organoid functionalization that were promising to forge a platform for engineering vascularized, innervated, immune-interactive and lipogenic SG organoids.
[Burns & Trauma]
|
|
|
|
|
|
|
|
Alpha-9 Oncology, Inc. announced that the first participant has been dosed in the Phase I study evaluating 68Ga-A9-3202, a radiodiagnostic targeting melanocortin 1 receptor for the imaging of locally advanced or metastatic melanoma.
[Alpha-9 Oncology, Inc.]
|
|
|
|
|
|
The Melanoma Research Alliance announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe. [Melanoma Research Alliance]
|
|
|
|
|
|
|
|
June 24 – 27, 2024 Barcelona, Spain
|
|
|
|
|
|
|
|
|
|
|
Karolinska Institute – Solna, Sweden
|
|
|
|
|
|
|
ETH Zurich – Zurich, Switzerland
|
|
|
|
|
|
|
University of Michigan – Ann Arbor, Michigan, United States
|
|
|
|
|
|
|
Institut Pasteur – Paris, France
|
|
|
|
|
|
|
Virginia Tech – Blacksburg, Virginia, United States
|
|
|
|
|
|